로딩 중…
지수 로딩 중…
Heron Therapeutics, Inc.
HRTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.42+7.80%
2026-06-18
Price Chart
Heron Therapeutics, Inc.-79.13%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $79M |
| Revenue | $151M |
| Net Income | $-31M |
| Total Assets | $246M |
| Net Assets | $9M |
| Value | |
| P/B | 8.65x |
| P/S | 0.52x |
| FCF Yield | -26.40% |
| Profitability | |
| ROA | -12.57% |
| Op. Margin | -6.94% |
| Revenue Growth | -10.78% |
| Earnings Growth | -407.82% |
| Financial Health | |
| Debt Ratio | 2594.71% |
| Total Debt | $142M |
| FCF | $-21M |
| Cash | $26M |
| Current Ratio | 2.53x |
| Performance | |
| 1Y Return | -79.13% |
| 1M Return | -50.77% |
| From 52W High | -81.85% |
| 1Y MDD | -82.87% |
| Trading | |
| Volume | 5,289,345 shares |
| Trading Value | $2M |
| Per Share | |
| EPS | $-0.12 |
| BPS | $0.09 |